Clinical trials in primary hepatocellular carcinoma: current status and future directions
- PMID: 2834053
- DOI: 10.1016/0305-7372(88)90007-2
Clinical trials in primary hepatocellular carcinoma: current status and future directions
Similar articles
-
Management of pediatric hepatocellular carcinoma: A multimodal approach.Pediatr Transplant. 2017 Sep;21(6). doi: 10.1111/petr.13007. Epub 2017 Jun 20. Pediatr Transplant. 2017. PMID: 28631359
-
Hepatocellular carcinoma: current questions and future directions.Clin Adv Hematol Oncol. 2015 Mar;13(3):176-9. Clin Adv Hematol Oncol. 2015. PMID: 26352425 No abstract available.
-
Hepatocellular carcinoma (primary cancer of the liver).Gastroenterol Clin Biol. 2006 Sep;30 Spec No 2:2S57-2S61. Gastroenterol Clin Biol. 2006. PMID: 17151564 Review. No abstract available.
-
Non-surgical treatment of hepatocellular carcinoma.Aliment Pharmacol Ther. 2002 Jan;16(1):1-15. doi: 10.1046/j.1365-2036.2002.01149.x. Aliment Pharmacol Ther. 2002. PMID: 11856073 Review.
-
Transcatheter arterial embolization in unresectable hepatocellular carcinoma.Cardiovasc Intervent Radiol. 1990 Jun-Jul;13(3):135-9. doi: 10.1007/BF02575464. Cardiovasc Intervent Radiol. 1990. PMID: 2171771
Cited by
-
AFP Response to Locoregional Therapy Can Stratify the Risk of Tumor Recurrence in HCC Patients after Living Donor Liver Transplantation.Cancers (Basel). 2023 Mar 1;15(5):1551. doi: 10.3390/cancers15051551. Cancers (Basel). 2023. PMID: 36900345 Free PMC article.
-
Crizotinib and Doxorubicin Cooperatively Reduces Drug Resistance by Mitigating MDR1 to Increase Hepatocellular Carcinoma Cells Death.Front Oncol. 2021 May 18;11:650052. doi: 10.3389/fonc.2021.650052. eCollection 2021. Front Oncol. 2021. PMID: 34094940 Free PMC article.
-
AP-2β inhibits hepatocellular carcinoma invasion and metastasis through Slug and Snail to suppress epithelial-mesenchymal transition.Theranostics. 2018 Jun 12;8(13):3707-3721. doi: 10.7150/thno.25166. eCollection 2018. Theranostics. 2018. PMID: 30026878 Free PMC article.
-
Resistance a major hindrance to chemotherapy in hepatocellular carcinoma: an insight.Cancer Cell Int. 2018 Mar 20;18:44. doi: 10.1186/s12935-018-0538-7. eCollection 2018. Cancer Cell Int. 2018. PMID: 29568237 Free PMC article. Review.
-
Locoregional and systemic therapy for hepatocellular carcinoma.J Gastrointest Oncol. 2017 Apr;8(2):215-228. doi: 10.21037/jgo.2017.03.13. J Gastrointest Oncol. 2017. PMID: 28480062 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical